Lotus Eye Hospital And Institute Ltd.
Snapshot View

50.60 -1.45 ▼-2.8%

05 August 2021, 04:00:00 P.M.
Volume: 686

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.lotuseye.org
Financial Indicators
Market Cap 108.24 Cr.
Earnings per share (EPS) 0.75 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 68.99 Trailing Twelve Months Ending 2021-03
Industry PE 202.10 Trailing Twelve Months Ending 2021-03
Book Value / Share 25.34 Trailing Twelve Months Ending 2021-03
Price to Book Value 2.05 Calculated using Price: 52.05
Dividend Yield 0.96 Period Ending 2020-03
No. of Shares Subscribed 2.08 Cr. 20,796,330 Shares
FaceValue 10
Company Profile

Lotus Eye Care Hospital  was originally incorporated as ‘Kalaivani Health Centre Pvt. Ltd.’on March 14,1997 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Tamil Nadu, Coimbatore. The name of the Company was changed to ‘Lotus Eye Care Hospital Pvt. Ltd. on January 23, 2006 and subsequently to ‘Lotus Eye Care Hospital Limited’ upon conversion into Public Limited Company on October 16, 2007 and a fresh certificate of incorporation has been obtained from Registrar of Companies, Tamil Nadu, Coimbatore.

Lotus Eye Care Hospital is a hi-tech super specialty eye care hospital catering its value added service to the society since inception

Lotus is known for its excellence in Ophthalmic services with personalized care. Lotus is committedly pioneering in the technological revolution in eye care and rendering service to thousands of patients from across the globe to see the world better than ever before.

In the year 1998 Lotus introduced Multi Scan Lasik and in the year 2002 Wave front based Esiris Custom Lasik for the first time in India. Lotus was the first Eye Hospital in South East Asia to have performed Epilasik in July 2004. In the year June 2005 Lotus introduced the most advanced technology of Zyoptix Z100 and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve Supervision.

Lotus has a vision of “empowering eyes to illuminate lives”. Lotus Eye Care group is marching towards its vision of becoming India’s best Corporate Hospital with branches in strategic locations where quality eye care is in need, and render world class eye care service to the society.

Dr.SK.Sundaramoorthy and his team of ophthalmic experts, who have highly qualified with vast experience in each specialty, render comprehensive eye care to hundreds of patients daily at their state of the art eye hospitals in Coimbatore, Tirupur and Salem in South India.

Services offered by the company:

  • Specialty Treatments 
  • Institute of Optometry 
  • Community ophthalmology  
  • Medical Tourism
  • Eye Bank

Milestones:

  • 1989- Opening of hospital at R.S.Puram, Coimbatore. The same was under management of LVRT from 1992 to 2006.
  • 2002- Opening of hospital at Peelamedu, Coimbatore
  • 2004 -Opening of hospital at Salem
  • 2007- Opening of hospital at Tirupur

Achievements/ recognition:

  • Lotus was the first Eye Hospital in South East Asia to have performed Epilasik in July 2004.
  • In the year June 2005 Lotus introduced the most advanced technology of Zyoptix Z100 and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve Supervision.
  • 2012 - Life Time Achievement Award to Dr.K.Sundramoorthy by The TamilnaduDr.M.G.R.Medical University.
  • 2014 - For the sake of Governor Award to Dr.K.Sundramoorthy by Rotary International.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-2.79%
1 Week
+11.21%
1 Month
-0.10%
3 Month
+12.44%
6 Month
+42.94%
1 Year
+73.29%
2 Year
+172.78%
5 Year
+221.27%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -4.34 0.81 0.08 -3.93 0.20 0.89 3.47 1.41 2.10
Return on Capital Employed (%) -4.20 0.99 0.27 -4.14 0.27 1.13 3.71 1.66 3.32
Return on Assets (%) -3.96 0.73 0.07 -3.45 0.18 0.81 3.12 1.25 1.88

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 51 51 51 49 49 50 51 50 51
Non Curr. Liab. 1 0 0 1 1 0 0 0 0
Curr. Liab. 5 5 7 6 5 4 7 6 6
Minority Int.
Equity & Liab. 56 57 59 56 55 55 57 56 58
Non Curr. Assets 52 49 52 51 48 48 49 49 47
Curr. Assets 4 7 7 5 6 7 8 7 11
Misc. Exp. not W/O 0 0
Total Assets 56 57 59 56 55 55 57 56 58

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 26 29 29 30 31 34 38 38 41
Other Income 0 1 0 0 1 1 1 1 1
Total Income 27 30 29 30 32 35 39 39 41
Total Expenditure -25 -26 -26 -29 -28 -31 -34 -35 -37
PBIDT 1 4 3 2 4 4 5 4 5
Interest 0 0 0 0 0 0 0 0 0
Depreciation -4 -3 -3 -4 -4 -3 -3 -3 -3
Taxation 0 0 0 0 0 0 0 0 0
Exceptional Items 0 0 0 0 -1
PAT -2 0 0 -2 0 0 2 1 1

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 2 4 4 2 3 3 6 4 5
Cash Fr. Inv. -3 -1 -5 -5 -1 -1 -4 -4 -1
Cash Fr. Finan. 0 0 -1 2 -1 0 -2 -1 0
Net Change -1 2 -1 0 2 2 0 -1 4
Cash & Cash Eqvt 0 2 1 1 2 3 4 3 7

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 57.27 57.55 57.68 57.68 57.68 57.68 57.71 57.74 57.74
Public 42.73 42.45 42.32 42.32 42.32 42.32 42.29 42.26 42.26
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Mon, 19 Jul 2021
Shareholding for the Period Ended June 30 2021
Lotus Eye Hospital And Institute Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here
Mon, 19 Jul 2021
Initial Disclosure With Reference To SEBI Circular No SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018.
This is to inform you that LOTUS EYE HOSPITAL AND INSTITUTE LIMITED is not identified as Large entity and hence is not required to make the initial disclosure.
Sat, 17 Jul 2021
Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Please Find Enclosed Disclosure Of Related Party Transactions For The Half-Year Ended March 31 2021.
Pursuant to regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed disclosure of related party transactions for the half-year ended March 31 2021.

Technical Scans View Details

Wed, 04 Aug 2021
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Closing Above Previous High Closing Above Previous High
Closing Above Previous High For 3 Days Closing Above Previous High For 3 Days

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 188,527.75 785.85 +0.0%
Divi's Laboratories Ltd. 131,785.24 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. 79,333.82 4,783.30 +0.2%
Cipla Ltd. 75,796.16 945.20 +0.6%
Cadila Healthcare Ltd. 60,170.47 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. 58,468.59 4,075.50 +0.2%
Piramal Enterprises Ltd. 57,915.28 2,601.15 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 31.40 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 66.41 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.66 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 31.52 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 28.20 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 388.86 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 43.47 2,601.15 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.94 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 14.18 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.44 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 4.15 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.63 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.72 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 1.69 2,601.15 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 0.10 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,601.15 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 14.13 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,601.15 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 17.85 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,601.15 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2020-03 6,969.40 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 19,159.59 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,601.15 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2020-03 1,984.29 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 2,401.30 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,601.15 +2.0%